20^th World Congress on Radiology and Oncology 26-27 September, 2018 Chicago, Illinois, USA

Greetings,

My name is Julie Ostrowski, I am the Chairman of the Board for the Illinois State Society of Radiologic Technologists (ISSRT), I want to welcome you to the 20^th World Congress on Radiology and Oncology.  I am thrilled it is being held in my state of residence, Illinois this year!

The World Congress is an excellent forum where people from all over the world come to share their research in Radiology and Oncology.  I want to encourage all attendees to join the Congress and explore the exciting research avenues their field has to offer.

I know the 2018 conference will be a great experience for all attending.  The latest insights and research developments in Radiology & Oncology will be shared, as well as an opportunity to experience all that Chicago Illinois offers.

Join me, and we can experience the 20^th World Congress together!

Julie Ostrowski, RT(R)(CT)(ARRT)

ISSRT, Chairman of the Board

National Radiology Speaker

Southwestern Illinois College Radiology Instructor

Southwestern Illinois College Computed Tomography Instructor

St. Louis University Instructor

Track1: Trends in Radiology

3D Printing

Artificial Intelligence

Tomography

Positron emission tomography

Angiography

Helical Computed Tomography

Diagnostic Radiology

MRI Magnetic Resonance Imaging

Vascular & Interventional Radiology

Track2: Medical Imaging

Elastography  

Tomography   

Radiography  

Magnetic Particle Imaging

Echocardiography

Tactile imaging

MRI Magnetic Resonance Imaging               

Track3: Radiology Imaging

(CT) / CAT scan

Fluoroscopy

PET imaging /PET scan

Ultrasound

Mammography

Endoscopy

X-ray

Track4: Radiopharmaceuticals

Radioisotopes

Radiopharmacy

Radiopharmacology

Track5: Oncology Ventures

Medical Oncology

Surgical oncology

Radiation Oncology

Immune-assisted Oncology

Psycho-Oncology

Track6: Organ-Specific Cancers

Prostrate cancer

Colorectal cancer

Oesophagal cancer

Breast & ovarian cancer

Head and neck cancer

Cervical cancer

Liver cancer

Pancreatic cancer

Brain cancer

Gastrointestinal cancer

Bile Duct Cancer

Bladder cancer

Bronchial cancer

Track7: Breast Cancer Imaging

Gene Mutation

MRI

Mammography

Ultrasound

Carcinoma

Track8: Cancer Screening and Genomics

Cancer genome atlas

Carcinogenesis and Mutagenesis

Epigenetic Silencing of Tumor cells

Molecular basis of clinical phenotypes

Track9: Cancer  Clinical  Trials

Phases of clinical trials

Innovations in patient and community engagement in clinical trials

Data monitoring for trials with an adaptive design

Heterogeneity of treatment effect in randomized clinical trials

Treating different ailments by clinical trials

Pre-clinical research leading to clinical trials

Track10: Cancer Therapies

 Chemotherapy

 Radiation Therapy

 Targeted Therapy

 Immunotherapy

 Precision Therapy

Gene Therapy

 Laser Therapy

 Palliative Care

 Integrative care

Track11: Cancer Screening ,Diagnosis & Prevention

Localized cancer Screening

Organ Cancer Screening

Infection Control

Track12: Cancer Chemotherapy & Pharmacology

Oncological pharmacotherapy

Drug development

Tumour Targeting Strategies

Clinical Trials

Anticancer Therapeutics        

Track13: Cancer Drug Resistance & Cancer Vaccine

Combination Strategies in Immuno-oncology

Novel Biomarker Discovery

Clinical Trials  , Biologics & Vaccines

Chemical Proteomics 

Molecular Profiling Techniques

Targeted drug therapies

Track14: Cancer Biopsy

Fine and core needle aspiration biopsy

Vacuum-assisted and suction biopsy

Image-guided biopsy

Incisional and Excisional biopsy

Shave and punch biopsy

Bone marrow aspiration and biopsy

Track15: Tumor biomarkers

Predictive Biomarker

Prognosis

PR/ER

Pharmacodynamics and pharmacokinetics                

Track16: Oncology & Hematology

Acute leukemia

Chronic leukemia

Lymphocytic leukemias

Myelogenous leukaemias

Use of Erythropoietin 

Anemia Management

Track17: Advancing Immunotherapy

Dendritic cell therapy

Sipuleucel-T   

Cytokine therapy

Adoptive T-cell therapy

Oncolytic virus therapy

Immunotherapy Vaccines

Immune checkpoint inhibitors           

Track18: Stem Cells

Stem Cell Transplant

Metastatic illness        

Track19: Radiation Oncology

3D conformal radiation therapy

Intensity-modulated radiation therapy (IMRT)

Volumetric modulated radiation therapy (VMAT)

Image-guided radiation therapy (IGRT)

Stereotactic radiosurgery (SRS)

Brachytherapy

Superficial x-ray radiation therapy (SXRT)

Intraoperative radiation therapy (IORT

Track20: Paediatric Oncology

Medulloblastoma

Osteosarcoma

Wilms Tumor

Neuroblastoma

Non-Hodgkin’s Lymphoma

Track21: Nuclear Medicine

Nuclear Medicine

Immunotherapy

Radiopharmaceuticals

Gamma camera

Track22: Alternative Medicine

The Gerson Therapy and Juicing.

Use of natural herbs

Homeopathy

Track23: Novel advancements in Cancer Radiology

Radionuclide Imaging

Molecular Diagnosis

Clinical Trials

Track24 Computer-assisted tomography

Positron Emission Tomography(PET)

Magnetic resonance imaging (MRI)

Track25: Elastography

Sono Elastography

MR Elastography

Track26: Dosimetry & Treatment Planning

Measuring Radiation Dose

Medical Dosimetry

Environmental Dosimetry

Radiation Exposure Monitoring

Track27: Medical Imaging software

ITK-Snap

NiftyRec

DTI-TK     

Track28: Advancements in Biomedical Research

Cancer Genetics

Biomedical Robotics

Biomedical Imaging

Track29: Case Reports

Epidemiology

Hematologic Case Reports

Radiology Case Reports

Oncology Case Reports

Cancer Case Reports

An increasing amount of population in the world has resulted in the growth of cancer. It is being estimated that cancer has affected more than 40% of the population globally. Considering the curing and aspects related to it the main agenda is to analyse the marketing potential of latest advancements, trends and innovations related to cancer treatment and techniques being used. Many organizations and associations have been putting effort to increase the productivity of various segments of cancer treatment Products.

Why Chicago?

Around 17% of the Chicago population of 30 years of age or older have been affected by cancer so that that even more than 15.4 million. They have been diagnosed with cancer. According to Novartis healthcare in 2015, nearly 4 million cancer surgeries were performed each year. Illinois is one of the best-suited hub for production of medicines among all the American states. Due to growing demands in America followed by Europe and Asia, have the biggest share of the international medical and surgical devices market. The markup for pharma industries in Chicago is far above the average markup for medicines than in European countries. Moreover, there arises a vast need to spread awareness regarding pre-surgical and post-surgical effects to patients.

Why to Attend?

Conference on Radiology and Oncology is a package of useful and latest advancements by professional researchers, doctors and Pharmacists specialized in cancer research and treatment to provide better life. An increasing amount of population in the world has resulted in growth of cancer. It is being estimated that, cancer has affected more than 40% of the population globally. Considering the curing and aspects related to it the main agenda is to analyse the marketing potential of latest advancements and therapies.  Conference is aimed at exploring and putting light on various ventures like advancements in clinical field of cancer biology and radiology for improvement of previous techniques and introduction to novel therapeutics, advancements in medical imaging  and radiology.

·         Radiology Imaging

·         Cancer Screening Test

·         Cancer  Clinical  Trials

·         Cancer Therapy

·         Cancer  Clinical  Trials

·         Oncology Surgery

·         Cancer Screening, Diagnosis & Prevention

·         Cancer Chemotherapy & Pharmacology

·         Cancer Drug Resistance & Cancer Vaccine

·         Nuclear Medicine

·         Paediatric Oncology

·         Novel advancements in Cancer radiology

·         Breast Cancer Imaging

·         Computer-assisted tomography

·         Medical Imaging software

·         Elastography

·         Radiopharmaceuticals

Importance and Scope:

Radiology is the term used for the treatment of cancer. The doctor who specializes in the Radiation Therapy is known as Radiologist. The vital role of the Radiologist is to diagnose the people who are suffering from cancer and explain the adverse effects during the treatment. There are different types of Radiologists in treating cancer.

This field of Radiology: Cancer treatment & its market is growing rapidly and its development is making an amazing impact in medical and health sciences and pharmaceuticals. The importance and significance can be calculated by the fact that it had made great advancements over the period of time and is continuing in various other sectors.

Research and development in Cancer science & Cancer Therapy addresses wide range of topics such as, neural processes underlying visually guided behavior, comparative anatomy and physiology of human systems, development of the cancerous drugs, regenerative medicine in Cancer therapy science, photoreceptor function to neuronal consciousness and awareness, diagnosis and treatment of cancer, machine and computational therapy.  

Cancer is the major issue worldwide and 14.1 million people are estimated to be affected by cancer worldwide out of which 8.2 million have died. Globally improper diagnosis is the main cause of moderate and severe Cancers; Tobacco remains the leading cause of Cancer in developed countries; Alcohol & others things are also leading causes of Cancer.

Global Market for Cancer Drugs

Cancer is a common term for a large group of diseases that can affect any organ of the body. Other terms used are malignant tumours and neoplasms. One of the significant features of cancer is the rapid creation of abnormal cells that grow beyond their usual margins, and which can then attack the adjoining parts of the body and spread to other organs. This process is referred to as metastasis. They are the major cause of death from cancer. Tobacco use, alcohol use, unhealthy diet and physical inactivity are the main cancer risk factors worldwide. Chronic infections from hepatitis B (HBV), hepatitis C virus (HCV) and some types of Kaposi’s sarcoma are leading risk factors for cancer in low- and middle-income countries

As there is a rapid growth in patients with Cancer and the cases of tumours and cancers are increasing every year. The worldwide cancer drugs market exceeds $161.30 billion (US) and is growing at more than 28% per year. Without the incorporation of consumer cancer chemotherapy drugs, the cancer products market is roughly an $89 billion market. Cancer drugs revenue was USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021. Oncology continues to be an area of active interest with a robust pipeline of over 600 molecules in the late-stage development of which 90% is a targeted therapy.